Treatment with angiotensin-converting-enzyme inhibitor for epirubicin-induced dilated cardiomyopathy
- 3 February 1996
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 347 (8997), 297-299
- https://doi.org/10.1016/s0140-6736(96)90469-9
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.Circulation, 1991
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureThe New England Journal of Medicine, 1987
- Doxorubicin-induced congestive heart failure in adultsCancer, 1985
- Risk Factors for Doxorubicin-lnduced Congestive Heart FailureAnnals of Internal Medicine, 1979
- Adriamycin cardiomyopathy—risk factorsCancer, 1977
- A clinicopathologic analysis of adriamycin cardiotoxicityCancer, 1973